Evidence map›Paper›PMID 37693456›Full record

ArticlebioRxiv : the preprint server for biology2023

Precision Proteoform Design for 4R Tau Isoform Selective Templated Aggregation.

Andrew P Longhini, Austin DuBose, Samuel Lobo, Vishnu Vijayan, Yeran Bai, Erica Keane Rivera, Julia Sala-Jarque, Arina Nikitina, Daniel C Carrettiero, Matthew Unger and 9 more

Open access · greenAbstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 4 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 3 institutions in 3 countries.

Andrew P LonghiniNeuroscience Research Institute, University of California Santa Barbara, Santa Barbara, California, USA.ORCID 0000-0002-0599-5030
Austin DuBoseDepartment of Chemistry and Biochemistry, University of California Santa Barbara, Santa Barbara, California, USA.
Samuel LoboDepartment of Chemical Engineering, University of California Santa Barbara, Santa Barbara, California, USA.
Vishnu VijayanDepartment of Chemistry and Biochemistry, University of California Santa Barbara, Santa Barbara, California, USA.
Yeran BaiNeuroscience Research Institute, University of California Santa Barbara, Santa Barbara, California, USA.
Erica Keane RiveraNeuroscience Research Institute, University of California Santa Barbara, Santa Barbara, California, USA.
Julia Sala-JarqueNeuroscience Research Institute, University of California Santa Barbara, Santa Barbara, California, USA.
Arina NikitinaNeuroscience Research Institute, University of California Santa Barbara, Santa Barbara, California, USA.
Daniel C CarrettieroNeuroscience Research Institute, University of California Santa Barbara, Santa Barbara, California, USA.
Matthew UngerNeuroscience Research Institute, University of California Santa Barbara, Santa Barbara, California, USA.
Olivia SclafaniNeuroscience Research Institute, University of California Santa Barbara, Santa Barbara, California, USA.
Valerie FuNeuroscience Research Institute, University of California Santa Barbara, Santa Barbara, California, USA.
Michael VigersDepartment of Chemistry and Biochemistry, University of California Santa Barbara, Santa Barbara, California, USA.
Luc BueeUniv. Lille, Inserm, CHU Lille, LilNCog - Lille Neuroscience & Cognition, F-59000 Lille, France.
Isabelle LandrieuCNRS EMR9002 - BSI - Integrative Structural Biology F-59000 Lille, France.
Scott ShellDepartment of Chemical Engineering, University of California Santa Barbara, Santa Barbara, California, USA.
Joan E SheaDepartment of Chemistry and Biochemistry, University of California Santa Barbara, Santa Barbara, California, USA.
Songi HanDepartment of Chemistry and Biochemistry, University of California Santa Barbara, Santa Barbara, California, USA.
Kenneth S KosikNeuroscience Research Institute, University of California Santa Barbara, Santa Barbara, California, USA.
University of California, Santa Barbara · USInserm · FRCentre National de la Recherche Scientifique · FR

Funding

Molecular Basis of the Tau Aggregation PathwayR01AG056058 · NIA · UNIVERSITY OF CALIFORNIA SANTA BARBARA · PI Songi Han, KENNETH Stephen KOSIK · 2017 to 2026
$6.4M
NIA NIH HHS R01 AG056058
6 · The paper itself

Abstract

Prion-like spread of disease-specific tau conformers is a hallmark of all tauopathies. A 19-residue probe peptide containing a P301L mutation and spanning the R2/R3 splice junction of tau, folds and stacks into seeding-competent fibrils and induces aggregation of 4R, but not 3R tau. These tau peptide fibrils propagate aggregated intracellular tau over multiple generations, have a high β-sheet content, a colocalized lipid signal, and adopt a well-defined U-shaped fold found in 4R tauopathy brain-derived fibrils. Fully atomistic replica exchange molecular dynamics (MD) simulations were used to compute the free energy landscapes of the conformational ensemble of the peptide monomers. These identified an aggregation-prohibiting β-hairpin structure and an aggregation-competent U-fold unique to 4R tauopathy fibrils. Guided by MD simulations, we identified that the N-terminal-flanking residues to PHF6, which slightly vary between 4R and 3R isoforms, modulate seeding. Strikingly, when a single amino acid switch at position 305 replaced the serine of 4R tau with a lysine from the corresponding position in the first repeat of 3R tau, the seeding induced by the 19-residue peptide was markedly reduced. Conversely, a 4R tau mimic with three repeats, prepared by replacing those amino acids in the first repeat with those amino acids uniquely present in the second repeat, recovered aggregation when exposed to the 19-residue peptide. These peptide fibrils function as partial prions to recruit naïve 4R tau-ten times the length of the peptide-and serve as a critical template for 4R tauopathy propagation. These results hint at opportunities for tau isoform-specific therapeutic interventions.

Indexed as

Amyloidogenic CoreBiological SciencesNeurosciencePrion-Like TemplatingProtein MisfoldingTauopathies

Identifiers

PMID37693456
PMCPMC10491155
OpenAlexW4386376476

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.